Hosoya, Kazutaka
Fujimoto, Daichi
Morimoto, Takeshi
Kumagai, Toru
Tamiya, Akihiro
Taniguchi, Yoshihiko
Yokoyama, Toshihide
Ishida, Tadashi
Matsumoto, Hirotaka
Hirano, Katsuya
Kominami, Ryota
Tomii, Keisuke
Suzuki, Hidekazu
Hirashima, Tomonori
Tanaka, Satoshi
Uchida, Junji
Morita, Mitsunori
Kanazu, Masaki
Mori, Masahide
Nagata, Kenji
Fukuda, Ikue
Tamiya, Motohiro
Article History
Received: 11 November 2020
Accepted: 16 March 2021
First Online: 1 April 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This retrospective study was approved by institutional review board in each institution. (Institutional Review Board in Osaka International Cancer Institute, the Research Ethics Review Committee in Kobe City Medical Center General Hospital, the Clinical Research Review Committee in National Hospital Organization Kinki-Chuo Chest Medical Center, the Medical ethics committee in Kurashiki Central Hospital, the Ethics Committee in Hyogo Prefectural Amagasaki General Medical Center, the Clinical Research Review Committee in National Hospital Organization Himeji Medical Center, the Medical Research Ethics Committee in Osaka Habikino Medical Center, the Clinical Research Review Committee in Osaka General Medical Center, the Clinical Research Review Committee in Kobe City Medical Center West Hospital, the Clinical Research Review Committee in National Hospital Organization Osaka Toneyama Medical Center, and the Research Ethics Committee in Itami City Hospital) The ethics committees waived the need for formal consents from the participants.
: Not applicable.
: Drs. Hosoya, Fujimoto, M. Tamiya, A. Tamiya, Hirano, and Mori have received lecture fees from Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan) and Merck Sharp & Dohme, Corp. (Tokyo, Japan). Drs. Yokoyama and Hirashima have received lecture fees from Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan). Drs. Kumagai, Taniguchi, Ishida, and Kanazu have received lecture fees from Merck Sharp & Dohme, Corp. (Tokyo, Japan). The remaining authors have no conflicts of interest to declare.